Report Fraud About Us What We Do

Bard Pelvic Mesh Class Action Settlement Bard Pelvic Mesh Settlement Consider The Consumer

Class Action Settlements

$60 Million in Settlement for the Bard Pelvic Mesh Lawsuit to be Distributed Among 48 States

What to Know About the Bard Pelvic Mesh Class Action Settlement

Medical device manufacturer, C.R. Bard and its parent company, Becton, Dickinson, and Company, were sued for allegedly deceiving consumers through the marketing of its surgical mesh devices and failing to disclose associated risks to women and doctors.

According to the class action lawsuit, thousands of women were injured by Bard’s surgical mesh devices and that the company failed to disclose that complications from using the devices “may persist as a permanent condition after a surgical intervention or other treatment.”

California’s Attorney General Xavier Becerra said that “misleading patients and neglecting to disclose risks or side effects of medical products is dangerous, irresponsible, even deadly. Bard was caught engaging in these shameful practices, and for that, they now pay.”

The class action lawsuits have been compiled and action was done simultaneously across multiple states.

Are you affected by the Bard Pelvic Mesh lawsuit and think that you are entitled to a settlement? Feel free to contact us today for help.

The Bard Pelvic Mesh Settlement Terms

Bard is settling the dispute with a monetary settlement as well as specific reforms across its corporate structure.

Bard has already discontinued selling and marketing its transvaginal mesh devices as of December 31, 2016, but the settlement terms will apply should they decide to reenter the market.

The settlement terms include:

  • Avoid misrepresentation of the safety of its pelvic mesh devices by omitting information about complications
  • Provide descriptions of complications in terms patients can understand, and include a list of certain complications in marketing materials that address the topic
  • Ensure that those who sell or market the products to health care providers report any patient complaints or adverse effects to Bard
  • Disclose its role as a sponsor for any clinical studies or data submitted for publication
  • Do not cite any clinical studies concerning surgical mesh if it failed to comply with the injunctive disclosure requirements, and any studies it sponsors must be registered with ClinicalTrials.gov.

If you’re affected by the Bard Pelvic Mesh settlement, we’d love to hear from you.

Editor’s note on the Bard Pelvic Mesh Class Action Settlement:

This piece is written about the recent Bard Pelvic Mesh Class Action Settlement. If you are considered eligible to be among the class of consumers described in the class action lawsuit settlement, you may eventually be able to participate in receiving any compensation the court may award.

If you believe that what is alleged in the Bard Pelvic Mesh class action settlement has affected you, please don’t hesitate to reach out to us.

Contact Us

We’d be happy to help you take a step in the right direction, fight this issue, and better enable you to join in on any potential consumer class action. If interested, please send an email to Outreach@ConsiderTheConsumer.com, find us on Twitter or Facebook, or even connect with us directly on our website! We look forward to hearing from you all.

Similarly, please check out our current list of Class Actions and Class Action Investigations, here.

Interested in articles like these? Become a subscriber below!

Interested in posts like these? Stay up to date with our newsletter!

No thoughts on “$60 Million in Settlement for the Bard Pelvic Mesh Lawsuit to be Distributed Among 48 States” yet. Be the first to speak your mind!

Leave a Reply